| Issue |
Section |
Title |
File |
| Vol 81, No 7 (2009) |
Editorial |
Clinical and epidemiological features of Berkitt's lymphoma |
|
| Vol 81, No 7 (2009) |
Editorial |
High-dose polychemotherapy of patients with poor-prognosis anaplastic T.0-large cell ALK+ lymphosarcoma |
|
| Vol 81, No 7 (2009) |
Editorial |
Pilot experience in the treatment of poor-prognosis primary diffuse large-B-cell lymphosarcoma of the bones and soft tissues with a modified program NHL-BFM-90 |
|
| Vol 81, No 7 (2009) |
Editorial |
Pilot experience of using modified high-dose therapy NHL-BFM-90 in diffuse large B-cell lymphosarcoma with primary skin involvement. A case report |
|
| Vol 81, No 7 (2009) |
Editorial |
Primary lymphoproliferative diseases of the central nervous system |
|
| Vol 82, No 7 (2010) |
Editorial |
Diffuse large B-cell lymphoma with primary involvement of mediastinal lymph nodes: diagnosis and treatment |
|
| Vol 90, No 7 (2018) |
Editorial |
Immunoglobulinopathies in patients with angioimmunoblastic T-cell lymphoma |
(Rus)
|
| Vol 90, No 7 (2018) |
Editorial |
First experience of using Brentuximab vedotin and modified program NHL-BFM-90 in the front-line treatment of patient with anaplastic large-cell lymphoma: a case report and a review of literature |
(Rus)
|
| Vol 90, No 7 (2018) |
Editorial |
Successful experience of treatment of a patient with generalized non-GCB- DLBCL using the R-mNHL-BFM-90 protocol with lenalidomide: case report and review of literature |
(Rus)
|
| Vol 93, No 7 (2021) |
Editorial |
Development of program therapy for patients with acute myeloid leukemia under the age of 60 years, based on the principles of differentiated effects |
(Rus)
|
